International Journal of Molecular Sciences (Apr 2020)

Dry Eye Disease and Tear Cytokine Levels—A Meta-Analysis

  • Matilde Roda,
  • Ivan Corazza,
  • Maria Letizia Bacchi Reggiani,
  • Marco Pellegrini,
  • Leonardo Taroni,
  • Giuseppe Giannaccare,
  • Piera Versura

DOI
https://doi.org/10.3390/ijms21093111
Journal volume & issue
Vol. 21, no. 9
p. 3111

Abstract

Read online

Background—It is recognized that inflammation is an underlying cause of dry eye disease (DED), with cytokine release involved. We systematically reviewed literature with meta-analyses to quantitatively summarize the levels of tear cytokines in DED. Methods—The PubMed, Embase, Web of Science, Ovid, Cochrane, and Scopus databases were reviewed until September 2019, and original articles investigating tear cytokines in DED patients were included. Differences of cytokines levels of DED patients and controls were summarized by standardized mean differences (SMD) using a random effects model. Study quality was assessed by applying Newcastle-Ottawa-Scale and the GRADE quality score. Methods of analytical procedures were included as covariate. Results—Thirteen articles investigating 342 DED patients and 205 healthy controls were included in the meta-analysis. The overall methodological quality of these studies was moderate. Systematic review of the selected articles revealed that DED patients had higher tear levels of interleukin (IL)-1β, IL-6, chemokine IL-8, IL-10, interferon-γ, IFN-γ, and tumor necrosis factor-α, TNF-α as compared to controls. Evidence was less strong for IL-2 and IL-17A. Conclusions—Data show that levels of tear cytokines in DED and control display a great variability, and further studies of higher quality enrolling a higher number of subjects are needed, to define a cut-off value.

Keywords